![]() during the COVID-19 public health emergency. Michael Feldman, vice chair for clinical services in the Department of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania, said in a statement.Ĭoncentriq Dx is CE-marked under the In Vitro Diagnostic Regulation (IVDR) and available for primary diagnosis in the U.S. The patents in question are US Patent Nos. NEW YORK Cancer genomics company Personalis announced on Tuesday that it has filed a lawsuit against Foresight Diagnostics, alleging it infringed patents related to whole-genome sequencing. ![]() “Digitization is one of the solutions to the systemic challenges plaguing the practice of pathology today,” Dr. Personalis Sues Foresight Diagnostics, Alleging Patent Infringement. This finding suggests a worsening shortage of available pathologists at a time when the global cancer burden is expected to rise. See reviews, photos, directions, phone numbers and more for Foresight Imaging locations in Los Angeles, CA. Proscia pointed to a recent analysis of the 2021 College of American Pathologists Practice Leader Survey which indicates that only 65% of practices looking to hire pathologists could fill all open positions, marking a decline from 2017. Find 3000 listings related to Foresight Imaging in Los Angeles on YP.com. The product brings together new features to help laboratory networks transition to 100% digital diagnosis and shift away from microscope-based pathology, Proscia said.Īccording to the Philadelphia-based firm, the expanded Concentriq Dx digital pathology platform consists of new features and enhancements including a user experience that engages pathologists, a collaboration mode that drives higher quality services, and an enterprise administration module that enables multisite networks to scale up more rapidly. ![]() Digital and computational pathology firm Proscia on Wednesday announced the CE marking and launch of the next version of its Concentriq Dx platform for primary diagnostic workflows. NEW YORK Foresight Diagnostics, a startup founded by Stanford University scientists, said Wednesday that it has closed a 12.5 million Series A financing led by Civilization Ventures and Bluebird Ventures, with participation by Pear Ventures.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |